| 5-HT | 5-hydroxytryptamine |
| 5-HT1A | 5-hydroxytryptamine receptor 1A |
| 5-HT2A | 5-hydroxytryptamine receptor 2A |
| ABC | ATP-binding cassette |
| ABCB1 | ATP-binding cassette subfamily B member 1 |
| AKI | acute kidney injury |
| APAP | acetaminophen |
| ATF4 | activating transcription factor 4 |
| ATF6 | activating transcription factor 6 |
| ATP | adenosine triphosphate |
| AUCtau | area under the plasma concentration–time curve over a dosing interval |
| BBB | blood–brain barrier |
| cAMP | cyclic adenosine monophosphate |
| CBD | cannabidiol |
| CHOP | C/EBP homologous protein |
| CI | confidence interval |
| Cmax | maximum plasma concentration |
| CNS | central nervous system |
| COMT | catechol-O-methyltransferase |
| COX | cyclooxygenase |
| CYP | cytochrome P450 |
| D2 | dopamine D2 receptor |
| DDI | drug–drug interaction |
| ER | endoplasmic reticulum |
| EPS | extrapyramidal symptoms |
| GABA | gamma-aminobutyric acid |
| GABA-A | gamma-aminobutyric acid type A receptor |
| GFR | glomerular filtration rate |
| GI | gastrointestinal |
| GPCR | G protein-coupled receptor |
| Gq/11 | Gq/11 family G protein |
| GSH | glutathione |
| hERG | human ether-à-go-go-related gene potassium channel |
| HLA | human leukocyte antigen |
| IKr | rapid delayed rectifier potassium current |
| IRE1α | inositol-requiring enzyme 1 alpha |
| JNK | c-Jun N-terminal kinase |
| KCNH2 | potassium voltage-gated channel subfamily H member 2 |
| MOR | μ-opioid receptor |
| NADPH | reduced nicotinamide adenine dinucleotide phosphate |
| NAPQI | N-acetyl-p-benzoquinone imine |
| NMDA | N-methyl-D-aspartate |
| NMS | neuroleptic malignant syndrome |
| NSAID | non-steroidal anti-inflammatory drug |
| OPRM1 | opioid receptor mu 1 |
| OR | odds ratio |
| PBPK | physiologically based pharmacokinetic |
| PERK | protein kinase R-like endoplasmic reticulum kinase |
| P-gp | P-glycoprotein |
| QSAR | quantitative structure–activity relationship |
| QTc | corrected QT interval |
| RCT | randomized controlled trial |
| RIDD | regulated IRE1-dependent decay |
| RNS | reactive nitrogen species |
| ROS | reactive oxygen species |
| SMILES | simplified molecular-input line-entry system |
| SNRI | serotonin–noradrenaline reuptake inhibitor |
| SSRI | selective serotonin reuptake inhibitor |
| TdP | torsades de pointes |
| THC | Δ9-tetrahydrocannabinol |
| UGT | UDP-glucuronosyltransferase |
| UGT2B7 | UDP-glucuronosyltransferase 2B7 |
| UPR | unfolded protein response |
| XBP1 | X-box binding protein 1 |
| ΔΨm | mitochondrial membrane potential |